AML Session Summary for Patients with Mikkael Sekeres - Secondary AML and Transplantation @AAMDSIF
AML Session Summary for Patients with Mikkael Sekeres - Secondary AML and Transplantation @AAMDSIF
Uploaded April 2025 | Updated September 2026, 18 hours ago
From the 2025 AAMDSIF Bone Marrow Failure Summit
Dr. Mikkael Sekeres explains the research presented at the summit about treatment options for secondary AML and transplantation for older adults with AML.

For more information about AML, or Acute Myeloid Leukemia, please visit aamds.org/diseases/acute-myeloid-leukemia-aml and aamds.org/education/patient-family-webinars
AML Session Summary for Patients with Mikkael Sekeres - Secondary AML and TransplantationAddressing Barriers and Challenges to Patient Care - 2023 Omaha Patient and Family Hybrid ConferenceNon-Transplant Therapies for Marrow Failure with Dr. Bhavisha Patel and Dr. Phillip Scheinberg2022 Webinar: When Does a PNH Clone Have Clinical Significance?AAMDSIF 40th Anniversary Summit: Advances in the Science and Treatment of PNHTransplant for MDS in Older Adults - with Mariam NawasUpdates from ASH22: Aplastic Anemia and PNH with Emma Groarke, MDCutaneous Graft versus Host Disease - Diagnosis and TreatmentPNH - 2022 San Antonio P&FVCUnderstanding Low Risk MDS 2021 Fall Patient Family ConferenceAAMDSIF 40th Anniversary Summit: Advances in the Science and Treatment of MDSAAMDSIF 40th Anniversary Summit: Advances in MDS, Myelodysplastic Syndromes
AAMDSIF |

AML Session Summary for Patients with Mikkael Sekeres - Secondary AML and Transplantation

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER